Lactose (India) Ltd | 134 Cr. | 95.0 | 247/84.3 | 25.9 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.47 Cr. | 2.86 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 35.3 Cr. | 47.6 | 94.9/45.2 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 32.9 Cr. | 22.5 | 29.1/13.1 | 32.3 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 67.8 Cr. | 90.0 | 155/79.0 | 15.5 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 61,226 Cr. | 2,170 | 2,286/1,275 | 46.5 | 314 | 0.11 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 333 Cr. | 14.6 | 29.0/11.2 | 20.7 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 404 Cr. | 855 | 904/635 | 19.4 | 299 | 0.08 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 122 Cr. | 24.5 | 32.0/14.6 | 41.5 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,133 Cr. | 385 | 449/198 | 14.8 | 123 | 0.67 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 39.0/22.8 | 45.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 12.1 Cr. | 4.85 | 10.4/2.11 | 134 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 318 Cr. | 327 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,317 Cr. | 1,222 | 1,584/1,078 | 56.1 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 180 Cr. | 0.97 | 1.37/0.53 | 24.0 | 1.12 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 61.2 Cr. | 25.5 | 26.3/6.40 | 63.1 | 16.0 | 0.00 % | 6.11 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 11.2 Cr. | 11.1 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 214 Cr. | 598 | 999/567 | 8.65 | 563 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 64.2 Cr. | 64.2 | 64.2/26.1 | 214 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 18.4 Cr. | 40.2 | 88.7/37.9 | 36.7 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 9.80 Cr. | 3.92 | 23.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.0 Cr. | 120 | 154/58.1 | 53.0 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 17.5 Cr. | 31.9 | 31.9/6.08 | 582 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 43.7 Cr. | 58.0 | 85.5/46.2 | 50.8 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.48 Cr. | 18.3 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,803 Cr. | 911 | 1,007/401 | 51.7 | 65.3 | 0.11 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 99.4 Cr. | 23.0 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.0 Cr. | 21.6 | 46.0/17.4 | 18.9 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 154 Cr. | 267 | 418/241 | 16.6 | 119 | 1.69 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 21.1 Cr. | 35.8 | 62.6/14.8 | 52.7 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 65,742 Cr. | 1,122 | 1,593/994 | 18.8 | 557 | 0.40 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 165 Cr. | 265 | 300/156 | 89.8 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,030 Cr. | 206 | 250/148 | 21.8 | 65.1 | 0.73 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 42.6 Cr. | 32.6 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.28 Cr. | 0.80 | 1.45/0.62 | 529 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 278 Cr. | 36.3 | 74.0/34.1 | 32.2 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.86 Cr. | 16.8 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 90.9 Cr. | 3.86 | 6.25/2.82 | 165 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 73,206 Cr. | 34,450 | 37,000/25,260 | 51.8 | 1,992 | 1.37 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,293 Cr. | 915 | 950/521 | 30.4 | 220 | 0.34 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 203 Cr. | 71.6 | 75.8/31.3 | 50.5 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 3,566 Cr. | 1,212 | 1,305/535 | | 78.1 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 28,957 Cr. | 1,782 | 1,870/750 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 891 Cr. | 272 | 330/154 | 29.2 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 619 Cr. | 463 | 487/270 | 15.8 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,179 Cr. | 594 | 950/512 | 30.6 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,866 Cr. | 1,320 | 1,923/991 | 26.2 | 754 | 0.75 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,12,726 Cr. | 3,331 | 3,591/2,870 | 58.9 | 224 | 0.95 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,147 Cr. | 125 | 317/115 | 38.4 | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,767 Cr. | 18.8 | 27.9/13.4 | 36.2 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,997 Cr. | 275 | 281/102 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,01,001 Cr. | 1,671 | 1,960/1,550 | 35.1 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,817 Cr. | 634 | 886/441 | 5,217 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,090 Cr. | 236 | 398/175 | 30.6 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 353 Cr. | 1,167 | 1,750/765 | 18.8 | 650 | 0.13 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,822 Cr. | 902 | 1,003/530 | 98.5 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,637 Cr. | 185 | 241/111 | 209 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 13,686 Cr. | 5,943 | 7,600/4,146 | 36.0 | 374 | 1.97 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 4,222 Cr. | 2,553 | 2,977/1,540 | 36.5 | 321 | 0.78 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 9,479 Cr. | 5,710 | 6,176/4,863 | 36.5 | 323 | 1.40 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 208 Cr. | 58.9 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 25,149 Cr. | 5,497 | 6,453/3,701 | 39.2 | 922 | 0.65 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 116 Cr. | 93.9 | 348/81.0 | 8.63 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,597 Cr. | 424 | 582/130 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,637 Cr. | 717 | 1,998/604 | 36.5 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 15,486 Cr. | 12,070 | 18,100/7,900 | 74.4 | 1,188 | 0.10 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 461 Cr. | 20.5 | 56.5/15.5 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 17,431 Cr. | 973 | 1,639/660 | 9.25 | 425 | 0.95 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,451 Cr. | 63.0 | 101/41.7 | 29.2 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 11,705 Cr. | 258 | 359/168 | 30.7 | 54.4 | 0.23 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 139 Cr. | 87.7 | 145/65.5 | 20.1 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 398 Cr. | 112 | 177/90.2 | 50.4 | 29.0 | 0.00 % | 9.91 % | 9.21 % | 10.0 |
Lupin Ltd | 86,235 Cr. | 1,888 | 2,403/1,766 | 26.2 | 377 | 0.42 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,103 Cr. | 551 | 980/499 | 13.4 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 42,987 Cr. | 797 | 800/390 | 126 | 84.6 | 0.15 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,198 Cr. | 1,154 | 1,235/483 | 30.1 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 180 Cr. | 83.4 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 865 Cr. | 179 | 370/155 | 22.4 | 107 | 1.71 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 746 Cr. | 464 | 500/271 | 29.9 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 18,629 Cr. | 1,169 | 1,310/701 | 33.6 | 393 | 0.43 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,171 Cr. | 1,613 | 2,030/1,303 | 38.2 | 221 | 0.76 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,610 Cr. | 242 | 328/132 | 40.5 | 36.1 | 0.83 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 36,498 Cr. | 1,439 | 1,758/1,168 | 42.1 | 274 | 0.28 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,687 Cr. | 91.5 | 108/57.5 | 26.6 | 57.5 | 1.11 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 93.6 Cr. | 17.3 | 34.7/12.0 | 12.0 | 74.3 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 632 Cr. | 104 | 186/67.2 | 7.63 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 3,020 Cr. | 327 | 388/190 | | 111 | 0.46 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,208 Cr. | 341 | 465/309 | 46.4 | 102 | 0.35 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,540 Cr. | 1,810 | 3,379/1,243 | 56.0 | 369 | 0.33 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,471 Cr. | 346 | 504/285 | 49.7 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 11,425 Cr. | 471 | 725/412 | 23.8 | 153 | 0.33 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 61,827 Cr. | 2,191 | 2,191/1,275 | 46.9 | 314 | 0.11 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 54,810 Cr. | 3,235 | 3,516/1,921 | 62.7 | 115 | 1.29 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 30,617 Cr. | 1,858 | 2,221/1,200 | 28.1 | 592 | 0.98 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 8,167 Cr. | 502 | 659/359 | 30.6 | 140 | 1.01 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 23,249 Cr. | 1,707 | 1,910/987 | 66.4 | 210 | 0.41 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,05,049 Cr. | 1,259 | 1,421/1,020 | 19.0 | 402 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,998 Cr. | 255 | 308/155 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,18,858 Cr. | 1,472 | 1,702/1,310 | 23.1 | 386 | 0.88 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,386 Cr. | 2,024 | 2,641/1,422 | 28.7 | 375 | 0.23 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 436 Cr. | 148 | 203/82.0 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,631 Cr. | 155 | 186/105 | 19.4 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 76.4 Cr. | 47.0 | 92.0/40.4 | 137 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 49,956 Cr. | 374 | 405/291 | 52.0 | 180 | 0.13 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,761 Cr. | 1,745 | 2,215/1,134 | 38.5 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 160 Cr. | 100 | 158/76.3 | 22.2 | 48.6 | 1.19 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 198 Cr. | 83.6 | 95.0/67.8 | 31.4 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,916 Cr. | 9,167 | 10,691/6,220 | 131 | 308 | 0.25 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,113 Cr. | 731 | 863/544 | 41.6 | 113 | 0.63 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 219 Cr. | 104 | 145/82.2 | 11.2 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 57,808 Cr. | 4,835 | 6,440/4,492 | 26.7 | 1,002 | 0.93 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 19,235 Cr. | 979 | 1,304/725 | 33.9 | 264 | 1.13 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 516 Cr. | 903 | 1,754/763 | 30.3 | 688 | 0.56 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 33,025 Cr. | 2,644 | 3,486/2,022 | 36.0 | 303 | 1.35 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,707 Cr. | 331 | 571/258 | 28.3 | 127 | 1.57 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,357 Cr. | 474 | 635/312 | 27.7 | 136 | 0.21 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 19,219.21 Cr | 1,199.64 | | 106.46 | 194.39 | 0.30% | 16.63% | 15.26% | 6.18 |